S100A6 and breast carcinoma: By disrupting the MDM2–HAUSP–DAXX-HAUSP-DAXX complex, S100A6 induces MDM2 self-ubiquitination and its degradation, which suppresses the growth of breast cancer and enhances its sensitivity to chemotherapy.